Source:http://linkedlifedata.com/resource/pubmed/id/17554336
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7151
|
pubmed:dateCreated |
2007-7-19
|
pubmed:abstractText |
Nuclear transplantation can reprogramme a somatic genome back into an embryonic epigenetic state, and the reprogrammed nucleus can create a cloned animal or produce pluripotent embryonic stem cells. One potential use of the nuclear cloning approach is the derivation of 'customized' embryonic stem (ES) cells for patient-specific cell treatment, but technical and ethical considerations impede the therapeutic application of this technology. Reprogramming of fibroblasts to a pluripotent state can be induced in vitro through ectopic expression of the four transcription factors Oct4 (also called Oct3/4 or Pou5f1), Sox2, c-Myc and Klf4. Here we show that DNA methylation, gene expression and chromatin state of such induced reprogrammed stem cells are similar to those of ES cells. Notably, the cells-derived from mouse fibroblasts-can form viable chimaeras, can contribute to the germ line and can generate live late-term embryos when injected into tetraploid blastocysts. Our results show that the biological potency and epigenetic state of in-vitro-reprogrammed induced pluripotent stem cells are indistinguishable from those of ES cells.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chromatin,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Homeodomain Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Nanog protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Octamer Transcription Factor-3,
http://linkedlifedata.com/resource/pubmed/chemical/Pou5f1 protein, mouse
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1476-4687
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
19
|
pubmed:volume |
448
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
318-24
|
pubmed:meshHeading |
pubmed-meshheading:17554336-Animals,
pubmed-meshheading:17554336-Cell Differentiation,
pubmed-meshheading:17554336-Cell Lineage,
pubmed-meshheading:17554336-Chimera,
pubmed-meshheading:17554336-Chromatin,
pubmed-meshheading:17554336-DNA Methylation,
pubmed-meshheading:17554336-DNA-Binding Proteins,
pubmed-meshheading:17554336-Female,
pubmed-meshheading:17554336-Fibroblasts,
pubmed-meshheading:17554336-Gene Silencing,
pubmed-meshheading:17554336-Homeodomain Proteins,
pubmed-meshheading:17554336-Male,
pubmed-meshheading:17554336-Mice,
pubmed-meshheading:17554336-Octamer Transcription Factor-3,
pubmed-meshheading:17554336-Pluripotent Stem Cells,
pubmed-meshheading:17554336-Teratoma
|
pubmed:year |
2007
|
pubmed:articleTitle |
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.
|
pubmed:affiliation |
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|